Cholesterol and Glucose Markers Linked to Mood

In a national US survey, adults with higher combined cholesterol and glucose readings had greater odds of depressive symptoms.

Updated on Nov. 3, 2026 in Mental Health

Cholesterol and Glucose Markers Linked to Mood

Live Poll

Do you think routine blood tests for cholesterol and blood sugar reveal mental health risks?

A cross-sectional study published in Psychiatry Research associated a higher cholesterol-HDL-glucose (CHG) index with increased odds of depressive symptoms among US adults. The analysis used nationally representative survey data, so the finding describes a population-level association rather than a diagnosis for any individual.

Why it matters

Cholesterol and blood sugar are routinely measured in primary care, so a link between a combined metabolic index and mood symptoms could eventually inform how clinicians think about screening for depression alongside metabolic health. The study does not establish that metabolic markers cause depression, and that distinction matters for how the finding is used.

This cross-sectional analysis of 8,596 US adults from the 2007 to 2018 National Health and Nutrition Examination Survey found that the highest CHG quartile had 1.66 times the odds of depressive symptoms compared with the lowest quartile after full adjustment. Because depressive symptoms were measured at a single point using the Patient Health Questionnaire-9, the design cannot establish the direction of the relationship over time.

The players

Psychiatry Research

A peer-reviewed journal that publishes research in psychiatry, including studies on mood disorders and their biological and behavioral correlates.

The details

The cholesterol-HDL-glucose index combines total cholesterol, high-density lipoprotein cholesterol and blood glucose into one measure, and the researchers examined how values across its range related to depressive symptoms. Depressive symptoms were defined by a Patient Health Questionnaire-9 score of at least 10, and the team used survey-weighted regression models to account for the national sampling design. Additional restricted cubic spline, subgroup, sensitivity and exploratory mediation analyses were run to test whether the association held across different analytic choices. Mediation analysis is exploratory, so any pathway it suggests should be treated as a hypothesis for future research rather than a confirmed mechanism.

NHANES data were collected between 2007 and 2018, the period this analysis draws on.
The study was published in Psychiatry Research in 2026.

Health Landscape

Much of the population-level work on depression and metabolic health has relied on nationally representative surveys such as NHANES, which can show associations across large samples but cannot track individuals over time. Longitudinal cohort studies and clinical trials remain the stronger tests for whether metabolic markers precede depressive symptoms, and this study points toward that next stage of research.

Adults who already have their cholesterol and glucose checked during routine visits may find it useful to mention any ongoing low mood or depressive symptoms at the same appointment. Anyone experiencing persistent sadness or loss of interest should raise it with a physician, who can discuss screening and appropriate next steps.

The takeaway

The study adds to evidence that metabolic health and mood may be connected, though it cannot show cause. Worth discussing with your doctor whether a routine lipid and glucose check should also prompt a conversation about mood.